Doganci et al. 36 found that i.n. administration of Abs against the IL-2Rβ ameliorated both inflammation and airway hyperresponsiveness in experimental allergic asthma, which could be explained by the different distribution of CD25 and CD122 between various T cells, too. Here, IL2RB is linked to allergic asthma.